Clinical Trial Update: TIL Therapy for Metastatic Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of tumor-infiltrating lymphocyte (TIL) therapy for metastatic ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• TIL therapy (tumor-infiltrating lymphocyte therapy)

Snippet

Sponsor: Inge Marie Svane | Conditions: Metastatic Ovarian Cancer | Phase 1 | Status: COMPLETED